基本信息 产品详情 公司简介 推荐产品
网站主页 AMYLOID PRECURSOR, HUMAN, 重组蛋白 (HFC) Amyloid Precursor, Human, 重组蛋白 (hFc)
  • Amyloid Precursor, Human, 重组蛋白 (hFc)|TMPJ-00782|TargetMol

Amyloid Precursor, Human, 重组蛋白 (hFc)|TMPJ-00782|TargetMol

Amyloid Precursor Protein, Human, Recombinant (hFc)
26700 1mg 起订
上海 更新日期:2025-11-17

TargetMol中国(陶术生物)

VIP2年
联系人:邵小姐
手机:15002134094 拨打
邮箱:marketing@targetmol.cn

产品详情:

中文名称:
Amyloid Precursor, Human, 重组蛋白 (hFc)
英文名称:
Amyloid Precursor Protein, Human, Recombinant (hFc)
品牌:
TargetMol
产地:
美国
保存条件:
Shipping with blue ice/Shipping at ambient temperature.
产品类别:
抑制剂
货号:
TMPJ-00782

Product Introduction

Bioactivity

名称Amyloid Precursor Protein, Human, Recombinant (hFc)
描述Amyloid precursor protein (APP) is a type I membrane protein with several isoforms due to alternative splicing, performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Of the three major splice isoforms of APP (APP695, APP751, and APP770) APP695 is the predominant neuronal form from which Amyloid beta peptide and transcriptionally-active cleaved intracellular domain of APP (AICD) are preferentially generated by selective processing through the amyloidogenic pathway. Human APP695 consists of a 17 amino acid (aa) signal sequence, a 607 aa extracellular domain (ECD), a 24 aa transmembrane domain, and a 47 aa cytoplasmic domain. Within the ECD, human APP695 shares 97% aa sequence identity with mouse and rat APP695. Amyloid beta is a major molecule implicated in pathogenesis of Alzheimer's disease (AD) and related dementias. AICD regulates expression by direct promoter binding of multiple genes, including APP itself, the beta-secretase, BACE-1 and the Amyloid beta-degrading enzyme, Neprilysin. As such, APP695 plays an important role in brain development, learning and memory, synaptic plasticity, and neurodegeneration including AD.
存储条件Shipping with blue ice/Shipping at ambient temperature.
关键字APP-695 | APP 695
APP695|||Amyloid Precursor Protein 695|||Amyloid Precursor|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (13年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,天然产物,生物化工,化学试剂,生物技术服务

Amyloid Precursor, Human, 重组蛋白 (hFc)相关厂家报价

内容声明
拨打电话 立即询价